跳至主要内容
临床试验/NCT05795309
NCT05795309招募中不适用

Automated Insulin Delivery in Type 1 Diabetes Complicated by Gastroparesis

Imperial College London2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2023年8月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
16
试验地点
2
主要终点
Percentage time spent in glucose target (3.9-10mmol/L)

研究概览

简要总结

This is a staggered randomised controlled trial that aims to assess the impact of an automated insulin delivery (AID) system on glucose, gastrointestinal and patient-reported outcomes.

详细描述

Following a run-in period of 2 weeks, participants will be randomised to control or hybrid automated insulin delivery (AID) using the 780G system and will remain in the intervention phase of the study for 12 weeks (4-week control, then 4-week AID or Control and finally 4-week AID). The total duration for each participant will be 14 weeks. There are 5 study visits (combination of face to face or/and remote) and two telephone visits in total.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 years of age or older
  • Type 1 diabetes confirmed on the basis of clinical features
  • Type 1 diabetes for greater than 1 year
  • On an intensified insulin regimen with multiple dose injection or insulin pump for > 3 months
  • HbA1c >7.5% (58mmol/mol) (or %TIR 3.9-10mmol/L <52% for participants already using a continuous glucose sensor)
  • Gastroparesis Cardinal Symptom Index (GCSI) ≥ 18 or evidence of delayed gastric emptying on nuclear medicine gastric emptying study

排除标准

  • Enrolled in other clinical trials
  • Estimated glomerular filtration rate of ≤30ml/min
  • Pregnant or planning pregnancy
  • Have active malignancy or under investigation for malignancy
  • Severe visual impairment
  • Reduced manual dexterity
  • Use of any automated insulin delivery system
  • Unable to participate due to other factors, as assessed by the Chief Investigator

结局指标

主要结局

Percentage time spent in glucose target (3.9-10mmol/L)

时间窗: 4 - 8 weeks

The change in percentage time in glucose target between baseline and intervention/control

次要结局

  • Percentage time spent in hyperglycaemia (>10mmol/L)(4 - 8 weeks)
  • Percentage time spent in hypoglycaemia (<3.9mmol/L)(4 - 8 weeks)
  • Percentage time spent in hypoglycaemia (<3.0mmol/L)(4 - 8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Automated Insulin Delivery in Type 1 Diabetes... | 临床试验